GS-9901

GS-9901 Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354; +17819995354
Email: marketing@targetmol.com
Products Intro: Product Name:GS-9901
CAS:1640247-87-5
Purity:98.00% Package:100 mg;500 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: Sichuan Wei Keqi Biological Technology Co., Ltd.  
Tel: 028-81700200 18116577057
Email: 3003855609@qq.com
Products Intro: Product Name:GS-9901
CAS:1640247-87-5
Purity:98% Package:5mg;10mg;20mg;50mg;100mg;200mg;500mg;1g
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Products Intro: Product Name:GS-9901
CAS:1640247-87-5
Purity:99.00% Package:1mg;5mg;10mg
Company Name: Shanghai Dexuan Pharmaceutical Technology Co., Ltd  
Tel: 1701086315
Email: dexuanpharma@126.com
Products Intro: Product Name:1640247-87-5
CAS:1640247-87-5
Purity:99% HPLC Package:1G;5G;10G;100G;1KG;
Company Name: TargetMol Chemicals Inc.  
Tel: 4008200310
Email: marketing@tsbiochem.com
Products Intro: Product Name:GS-9901
CAS:1640247-87-5
Purity:99.80% Package:1removed
GS-9901 Basic information
Product Name:GS-9901
Synonyms:GS-9901;GS 9901,GS9901;5-Pyrimidinecarbonitrile, 2,4-diamino-6-[[(S)-[5-chloro-8-fluoro-3,4-dihydro-4-oxo-3-(3-pyridinyl)-2-quinazolinyl]cyclopropylmethyl]amino]-
CAS:1640247-87-5
MF:C22H17ClFN9O
MW:477.88
EINECS:
Product Categories:
Mol File:1640247-87-5.mol
GS-9901 Structure
GS-9901 Chemical Properties
Boiling point 862.7±75.0 °C(Predicted)
density 1.71±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility Soluble in DMSO
form Solid
pka3.94±0.12(Predicted)
color White to off-white
Safety Information
MSDS Information
GS-9901 Usage And Synthesis
UsesGS-9901 is a highly selective and orally active PI3Kδ inhibitor, with an IC50 of 1 nM. Has potential to treat rheumatoid arthritis[1].
in vivo

GS-9901 (0.3/1/3 mg/kg, orally, twice daily for 7 days) demonstrates efficacy in a rat model of arthritis and is predicted to be suitable for q.d. dosing in humans[1].

Animal Model:Female Lewis rats with established collagen-induced arthritis (CIA)[1].
Dosage:0.3 mg/kg, 1 mg/kg, and 3 mg/kg.
Administration:Orally, twice-daily for 7 days starting on the 10th day after the second collagen immunization.
Result:Demonstrated significant reduction in ankle swelling in rats treated with 0.3 mg/kg 35 (31% reduction), 1 mg/kg 35 (67%), and 3 mg/kg 35 (65%).
Plasma concentrations measured on day 7 (12 h after last dose) were consistent with maintaining approximately 60%, 80%, and >90% inhibition of PI3Kδ at 0.3, 1.0, and 3 mg/kg doses, respectively, at trough levels.
IC 50PI3Kδ: 1 nM (IC50)
References[1] Patel L, et al. Discovery of Orally Efficacious Phosphoinositide 3-Kinase δ Inhibitors with Improved Metabolic Stability. J Med Chem. 2016 Oct 13;59(19):9228-9242. DOI:10.1021/acs.jmedchem.6b01169
GS-9901 Preparation Products And Raw materials
Tag:GS-9901(1640247-87-5) Related Product Information